AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 |Industry: Pharmaceuticals
|Expensive Performer
3369.50 -0.35 (-0.01%)
NSE Jul 30, 2021 15:31 PM
Volume: 11,142
 

3369.50
-0.01%
AstraZeneca covid-19 antibody treatment suffers setback
AstraZeneca covid-19 antibody treatment suffers setback
livemint
Drug's efficacy as post-infection therapy falls short in clinical trial, but potential preventative use is still undergoing testing
default
Recommended
More from AstraZeneca Pharma India Ltd.